| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.817 | 0.013 | 0.92 | Antiinflammatory | 0.866 0.008 DBMET00159 0.79 0.017 DBMET00160 0.841 0.01 DBMET01259 0.92 0.005 DBMET01260 0.91 0.005 DBMET01261 | DBMET01260 | |
| 0.712 | 0.004 | 0.762 | Superoxide dismutase inhibitor | 0.719 0.004 DBMET00159 0.762 0.003 DBMET01259 0.191 0.128 DBMET01260 | DBMET01259 | |
| 0.657 | 0.029 | 0.785 | Caspase 9 stimulant | 0.583 0.039 DBMET00159 0.486 0.065 DBMET00160 0.785 0.013 DBMET01260 0.544 0.046 DBMET01261 | DBMET01260 | |
| 0.629 | 0.004 | 0.862 | Non-steroidal antiinflammatory agent | 0.602 0.004 DBMET00159 0.43 0.01 DBMET00160 0.404 0.013 DBMET01259 0.812 0.003 DBMET01260 0.862 0.003 DBMET01261 | DBMET01261 | |
| 0.611 | 0.004 | 0.672 | Cyclooxygenase 1 inhibitor | 0.672 0.004 DBMET00159 0.389 0.008 DBMET00160 0.58 0.004 DBMET01259 0.415 0.006 DBMET01260 0.428 0.006 DBMET01261 | DBMET00159 | |
| 0.6 | 0.004 | 0.648 | Amyloid beta precursor protein antagonist | 0.648 0.004 DBMET00159 0.164 0.086 DBMET00160 0.447 0.005 DBMET01259 0.213 0.049 DBMET01260 0.335 0.011 DBMET01261 | DBMET00159 | |
| 0.604 | 0.018 | 0.757 | Cholesterol antagonist | 0.631 0.015 DBMET00159 0.513 0.031 DBMET00160 0.69 0.009 DBMET01259 0.744 0.005 DBMET01260 0.757 0.005 DBMET01261 | DBMET01261 | |
| 0.592 | 0.02 | 0.661 | Aldehyde oxidase inhibitor | 0.661 0.012 DBMET00159 | DBMET00159 | |
| 0.566 | 0.005 | 0.594 | Anesthetic general | 0.594 0.005 DBMET00159 0.241 0.054 DBMET00160 0.147 0.117 DBMET01259 0.508 0.007 DBMET01260 0.55 0.005 DBMET01261 | DBMET00159 | |
| 0.535 | 0.039 | 0.878 | Transcription factor NF kappa B inhibitor | 0.586 0.033 DBMET00159 0.624 0.028 DBMET00160 0.366 0.072 DBMET01259 0.878 0.008 DBMET01260 0.828 0.011 DBMET01261 | DBMET01260 | |
| 0.499 | 0.005 | 0.499 | Calcium channel activator | 0.464 0.009 DBMET00159 0.232 0.169 DBMET00160 0.328 0.066 DBMET01259 0.26 0.136 DBMET01261 | ||
| 0.516 | 0.024 | 0.644 | Histamine release inhibitor | 0.562 0.014 DBMET00159 0.387 0.082 DBMET00160 0.497 0.03 DBMET01259 0.637 0.007 DBMET01260 0.644 0.007 DBMET01261 | DBMET01261 | |
| 0.506 | 0.018 | 0.535 | Lipoxygenase inhibitor | 0.535 0.014 DBMET00159 0.207 0.133 DBMET01259 | DBMET00159 | |
| 0.457 | 0.005 | 0.486 | Cyclooxygenase inhibitor | 0.486 0.005 DBMET00159 0.296 0.018 DBMET00160 0.393 0.008 DBMET01259 0.327 0.014 DBMET01260 0.345 0.011 DBMET01261 | DBMET00159 | |
| 0.439 | 0.009 | 0.46 | Sodium/bile acid cotransporter inhibitor | 0.46 0.006 DBMET00159 0.419 0.012 DBMET00160 0.427 0.011 DBMET01259 0.436 0.009 DBMET01260 0.397 0.018 DBMET01261 | DBMET00159 | |
| 0.468 | 0.044 | 0.518 | 5 Hydroxytryptamine release inhibitor | 0.487 0.037 DBMET00159 0.328 0.136 DBMET00160 0.448 0.053 DBMET01260 0.518 0.027 DBMET01261 | DBMET01261 | |
| 0.427 | 0.004 | 0.748 | Cyclooxygenase 3 inhibitor | 0.414 0.004 DBMET00159 0.366 0.004 DBMET00160 0.157 0.043 DBMET01259 0.638 0.002 DBMET01260 0.748 0.001 DBMET01261 | DBMET01261 | |
| 0.43 | 0.021 | 0.491 | Amyloid beta aggregation inhibitor | 0.491 0.015 DBMET00159 0.192 0.082 DBMET01259 0.307 0.044 DBMET01260 0.342 0.036 DBMET01261 | DBMET00159 | |
| 0.429 | 0.024 | 0.645 | Antiamyloidogenic | 0.425 0.025 DBMET00159 0.227 0.082 DBMET00160 0.163 0.13 DBMET01259 0.645 0.006 DBMET01260 0.53 0.013 DBMET01261 | DBMET01260 | |
| 0.406 | 0.007 | 0.441 | Interleukin 6 antagonist | 0.441 0.005 DBMET00159 0.257 0.022 DBMET00160 0.181 0.054 DBMET01259 0.274 0.019 DBMET01260 0.433 0.006 DBMET01261 | DBMET00159 | |
| 0.44 | 0.071 | 0.827 | Cyclophilin D inhibitor | 0.509 0.047 DBMET00159 0.477 0.057 DBMET00160 0.533 0.041 DBMET01259 0.755 0.009 DBMET01260 0.827 0.005 DBMET01261 | DBMET01261 | |
| 0.39 | 0.027 | 0.459 | Hypolipemic | 0.422 0.021 DBMET00159 0.38 0.029 DBMET00160 0.301 0.048 DBMET01259 0.416 0.022 DBMET01260 0.459 0.016 DBMET01261 | DBMET01261 | |
| 0.382 | 0.031 | 0.717 | Hypoglycemic | 0.431 0.023 DBMET00159 0.261 0.07 DBMET00160 0.607 0.008 DBMET01260 0.717 0.005 DBMET01261 | DBMET01261 | |
| 0.367 | 0.023 | 0.367 | Platelet aggregation inhibitor | 0.254 0.05 DBMET00159 0.192 0.087 DBMET01261 | ||
| 0.37 | 0.038 | 0.402 | Hypoxia-inducible factor 1 alpha inhibitor | 0.37 0.039 DBMET00159 0.27 0.083 DBMET01260 0.402 0.029 DBMET01261 | DBMET01261 | |
| 0.343 | 0.012 | 0.343 | Gastrin inhibitor | 0.342 0.013 DBMET00159 0.271 0.057 DBMET01259 0.241 0.09 DBMET01260 0.302 0.031 DBMET01261 | ||
| 0.393 | 0.066 | 0.569 | Immunosuppressant | 0.427 0.054 DBMET00159 0.49 0.036 DBMET00160 0.351 0.086 DBMET01259 0.569 0.017 DBMET01260 0.555 0.02 DBMET01261 | DBMET01260 | |
| 0.379 | 0.055 | 0.779 | Antithrombotic | 0.418 0.045 DBMET00159 0.347 0.065 DBMET00160 0.625 0.014 DBMET01259 0.65 0.011 DBMET01260 0.779 0.005 DBMET01261 | DBMET01261 | |
| 0.333 | 0.01 | 0.351 | Cyclooxygenase 2 inhibitor | 0.351 0.009 DBMET00159 0.212 0.027 DBMET00160 0.308 0.012 DBMET01259 0.229 0.024 DBMET01260 0.247 0.02 DBMET01261 | DBMET00159 | |
| 0.345 | 0.027 | 0.378 | 5 Hydroxytryptamine uptake stimulant | 0.378 0.018 DBMET00159 | DBMET00159 | |
| 0.357 | 0.044 | 0.729 | Antioxidant | 0.47 0.024 DBMET00159 0.512 0.019 DBMET00160 0.48 0.022 DBMET01259 0.729 0.005 DBMET01260 0.682 0.006 DBMET01261 | DBMET01260 | |
| 0.352 | 0.052 | 0.567 | Spasmolytic | 0.376 0.045 DBMET00159 0.185 0.133 DBMET00160 0.304 0.068 DBMET01259 0.567 0.016 DBMET01260 0.467 0.028 DBMET01261 | DBMET01260 | |
| 0.407 | 0.11 | 0.73 | Apoptosis agonist | 0.43 0.1 DBMET00159 0.655 0.038 DBMET00160 0.73 0.026 DBMET01260 0.619 0.045 DBMET01261 | DBMET01260 | |
| 0.327 | 0.032 | 0.533 | Peroxidase inhibitor | 0.533 0.007 DBMET00159 0.174 0.067 DBMET01259 | DBMET00159 | |
| 0.385 | 0.091 | 0.542 | Analgesic | 0.542 0.038 DBMET00159 0.308 0.135 DBMET01260 0.224 0.21 DBMET01261 | DBMET00159 | |
| 0.304 | 0.01 | 0.315 | Succinate dehydrogenase inhibitor | 0.315 0.009 DBMET00159 0.229 0.031 DBMET01259 0.152 0.108 DBMET01261 | DBMET00159 | |
| 0.317 | 0.026 | 0.428 | Tyrosine 3 hydroxylase inhibitor | 0.428 0.006 DBMET00159 0.199 0.138 DBMET01259 | DBMET00159 | |
| 0.36 | 0.07 | 0.36 | Vasodilator, peripheral | 0.331 0.082 DBMET00159 0.325 0.085 DBMET01260 0.277 0.109 DBMET01261 | ||
| 0.333 | 0.043 | 0.633 | Free radical scavenger | 0.436 0.024 DBMET00159 0.415 0.026 DBMET00160 0.248 0.069 DBMET01259 0.633 0.007 DBMET01260 0.612 0.008 DBMET01261 | DBMET01260 | |
| 0.295 | 0.006 | 0.487 | ATPase inhibitor | 0.306 0.005 DBMET00159 0.334 0.005 DBMET00160 0.331 0.005 DBMET01260 0.487 0.003 DBMET01261 | DBMET01261 | |
| 0.344 | 0.058 | 0.48 | Vasodilator, coronary | 0.308 0.081 DBMET00159 0.236 0.148 DBMET00160 0.48 0.018 DBMET01260 0.479 0.019 DBMET01261 | DBMET01260 | |
| 0.296 | 0.017 | 0.471 | Protein kinase stimulant | 0.324 0.014 DBMET00159 0.223 0.034 DBMET00160 0.383 0.009 DBMET01260 0.471 0.005 DBMET01261 | DBMET01261 | |
| 0.29 | 0.012 | 0.455 | Chelator | 0.455 0.005 DBMET00159 0.125 0.049 DBMET01259 0.151 0.035 DBMET01260 0.174 0.029 DBMET01261 | DBMET00159 | |
| 0.3 | 0.022 | 0.506 | Melanin inhibitor | 0.33 0.018 DBMET00159 0.206 0.038 DBMET00160 0.419 0.011 DBMET01260 0.506 0.007 DBMET01261 | DBMET01261 | |
| 0.299 | 0.024 | 0.32 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.32 0.018 DBMET00159 0.241 0.047 DBMET01260 0.231 0.052 DBMET01261 | DBMET00159 | |
| 0.311 | 0.045 | 0.413 | Interleukin antagonist | 0.413 0.029 DBMET00159 0.157 0.113 DBMET01260 0.207 0.08 DBMET01261 | DBMET00159 | |
| 0.276 | 0.01 | 0.565 | Expectorant | 0.254 0.012 DBMET00159 0.308 0.008 DBMET00160 0.112 0.057 DBMET01259 0.53 0.003 DBMET01260 0.565 0.003 DBMET01261 | DBMET01261 | |
| 0.266 | 0.005 | 0.266 | Mucolytic | 0.251 0.006 DBMET00159 0.248 0.006 DBMET00160 0.145 0.035 DBMET01259 0.258 0.006 DBMET01260 0.237 0.008 DBMET01261 | ||
| 0.272 | 0.016 | 0.44 | Insulin secretagoues | 0.298 0.013 DBMET00159 0.306 0.012 DBMET01260 0.44 0.005 DBMET01261 | DBMET01261 | |
| 0.257 | 0.005 | 0.289 | HIV-1 integrase (Overall Integration) inhibitor | 0.289 0.004 DBMET00159 0.223 0.008 DBMET01259 | DBMET00159 | |
| 0.256 | 0.005 | 0.265 | Arachidonic acid antagonist | 0.265 0.004 DBMET00159 0.201 0.032 DBMET00160 0.23 0.012 DBMET01259 0.205 0.029 DBMET01260 0.222 0.016 DBMET01261 | DBMET00159 | |
| 0.269 | 0.019 | 0.285 | Phospholipase A2 inhibitor | 0.285 0.016 DBMET00159 0.162 0.064 DBMET00160 0.227 0.031 DBMET01259 0.218 0.034 DBMET01260 0.222 0.032 DBMET01261 | DBMET00159 | |
| 0.277 | 0.028 | 0.437 | Thrombolytic | 0.329 0.019 DBMET00159 0.151 0.081 DBMET00160 0.387 0.012 DBMET01259 0.346 0.017 DBMET01260 0.437 0.008 DBMET01261 | DBMET01261 | |
| 0.275 | 0.026 | 0.356 | Neurotrophic factor enhancer | 0.354 0.009 DBMET00159 0.188 0.089 DBMET00160 0.307 0.016 DBMET01260 0.356 0.009 DBMET01261 | DBMET01261 | |
| 0.316 | 0.071 | 0.338 | Caspase 3 stimulant | 0.294 0.082 DBMET00159 0.32 0.07 DBMET01260 0.338 0.063 DBMET01261 | DBMET01261 | |
| 0.242 | 0.006 | 0.344 | Interleukin 8 antagonist | 0.344 0.004 DBMET00159 0.145 0.037 DBMET01259 0.159 0.029 DBMET01261 | DBMET00159 | |
| 0.251 | 0.015 | 0.32 | Cystathionine beta-synthase inhibitor | 0.32 0.008 DBMET00159 0.125 0.054 DBMET00160 0.177 0.03 DBMET01260 0.243 0.016 DBMET01261 | DBMET00159 | |
| 0.247 | 0.015 | 0.436 | Cell adhesion inhibitor | 0.236 0.017 DBMET00159 0.11 0.074 DBMET00160 0.192 0.027 DBMET01259 0.316 0.009 DBMET01260 0.436 0.005 DBMET01261 | DBMET01261 | |
| 0.309 | 0.079 | 0.519 | Apoptosis antagonist | 0.345 0.058 DBMET00159 0.237 0.14 DBMET00160 0.472 0.024 DBMET01260 0.519 0.018 DBMET01261 | DBMET01261 | |
| 0.286 | 0.063 | 0.389 | DNA damaging | 0.292 0.06 DBMET00159 0.192 0.123 DBMET00160 0.389 0.031 DBMET01260 0.319 0.05 DBMET01261 | DBMET01260 | |
| 0.238 | 0.019 | 0.304 | Cholesterol synthesis inhibitor | 0.263 0.016 DBMET00159 0.162 0.039 DBMET00160 0.304 0.011 DBMET01259 0.17 0.036 DBMET01260 0.17 0.036 DBMET01261 | DBMET01259 | |
| 0.225 | 0.007 | 0.249 | ABCA1 expression enhancer | 0.249 0.006 DBMET00159 0.085 0.076 DBMET00160 0.149 0.018 DBMET01259 0.109 0.04 DBMET01261 | DBMET00159 | |
| 0.307 | 0.09 | 0.307 | Thyroid hormone antagonist | 0.278 0.106 DBMET00159 | ||
| 0.223 | 0.007 | 0.273 | TRPA1 agonist | 0.273 0.005 DBMET00159 0.118 0.06 DBMET00160 0.211 0.009 DBMET01259 0.144 0.036 DBMET01260 0.161 0.024 DBMET01261 | DBMET00159 | |
| 0.234 | 0.022 | 0.234 | Interleukin 1 antagonist | 0.22 0.026 DBMET00159 0.129 0.076 DBMET01261 | ||
| 0.261 | 0.049 | 0.53 | Nitric oxide antagonist | 0.306 0.039 DBMET00159 0.307 0.039 DBMET00160 0.196 0.069 DBMET01259 0.53 0.014 DBMET01260 0.496 0.016 DBMET01261 | DBMET01260 | |
| 0.256 | 0.045 | 0.321 | DNA methyltransferase I inhibitor | 0.242 0.05 DBMET00159 0.321 0.02 DBMET01260 0.314 0.022 DBMET01261 | DBMET01260 | |
| 0.246 | 0.037 | 0.246 | Insulin sensitizer | 0.244 0.038 DBMET00159 0.189 0.085 DBMET01259 0.177 0.099 DBMET01260 0.219 0.055 DBMET01261 | ||
| 0.21 | 0.004 | 0.247 | Liver X receptor alpha agonist | 0.247 0.003 DBMET00159 0.037 0.035 DBMET01261 | DBMET00159 | |
| 0.271 | 0.065 | 0.428 | Interleukin agonist | 0.304 0.046 DBMET00159 0.174 0.145 DBMET00160 0.428 0.015 DBMET01260 0.426 0.015 DBMET01261 | DBMET01260 | |
| 0.237 | 0.032 | 0.237 | Histone acetyltransferase inhibitor | 0.234 0.033 DBMET00159 | ||
| 0.208 | 0.004 | 0.251 | Bile acid receptor antagonist | 0.251 0.004 DBMET00159 0.103 0.043 DBMET00160 0.238 0.004 DBMET01259 0.114 0.026 DBMET01260 0.132 0.012 DBMET01261 | DBMET00159 | |
| 0.239 | 0.037 | 0.257 | Lipocortins synthesis antagonist | 0.257 0.031 DBMET00159 0.151 0.103 DBMET00160 0.153 0.1 DBMET01259 0.182 0.069 DBMET01260 0.201 0.055 DBMET01261 | DBMET00159 | |
| 0.227 | 0.027 | 0.495 | Alpha-N-acetylglucosaminidase inhibitor | 0.363 0.011 DBMET00159 0.134 0.066 DBMET00160 0.125 0.073 DBMET01259 0.409 0.008 DBMET01260 0.495 0.005 DBMET01261 | DBMET01261 | |
| 0.287 | 0.087 | 0.33 | 12-Lipoxygenase inhibitor | 0.33 0.065 DBMET00159 | DBMET00159 | |
| 0.277 | 0.078 | 0.317 | 5 Hydroxytryptamine release stimulant | 0.317 0.065 DBMET00159 0.229 0.101 DBMET01260 0.203 0.118 DBMET01261 | DBMET00159 | |
| 0.277 | 0.087 | 0.277 | Nootropic | 0.257 0.102 DBMET00159 0.195 0.165 DBMET01259 | ||
| 0.224 | 0.036 | 0.536 | Amylase inhibitor | 0.26 0.025 DBMET00159 0.112 0.086 DBMET00160 0.467 0.007 DBMET01260 0.536 0.005 DBMET01261 | DBMET01261 | |
| 0.192 | 0.004 | 0.235 | GABA B receptor agonist | 0.235 0.003 DBMET00159 0.105 0.013 DBMET01259 | DBMET00159 | |
| 0.191 | 0.004 | 0.191 | Peroxisome proliferator-activated receptor gamma antagonist | 0.154 0.005 DBMET00159 0.071 0.051 DBMET00160 0.09 0.022 DBMET01259 0.079 0.035 DBMET01261 | ||
| 0.24 | 0.054 | 0.372 | DNA methylase inhibitor | 0.228 0.061 DBMET00159 0.372 0.014 DBMET01260 0.327 0.021 DBMET01261 | DBMET01260 | |
| 0.216 | 0.029 | 0.624 | Monophenol monooxygenase inhibitor | 0.292 0.019 DBMET00159 0.16 0.043 DBMET00160 0.141 0.05 DBMET01259 0.624 0.005 DBMET01260 0.551 0.006 DBMET01261 | DBMET01260 | |
| 0.207 | 0.021 | 0.228 | Toll-Like receptor 2 antagonist | 0.228 0.014 DBMET00159 0.114 0.084 DBMET01260 | DBMET00159 | |
| 0.198 | 0.012 | 0.207 | Sphingosine 1-phosphate receptor 5 antagonist | 0.207 0.009 DBMET00159 | DBMET00159 | |
| 0.196 | 0.013 | 0.196 | Vanilloid 1 agonist | 0.192 0.014 DBMET00159 0.129 0.069 DBMET00160 0.155 0.033 DBMET01259 0.167 0.025 DBMET01260 0.169 0.024 DBMET01261 | ||
| 0.192 | 0.01 | 0.306 | Cell adhesion molecule inhibitor | 0.166 0.012 DBMET00159 0.191 0.01 DBMET01259 0.206 0.009 DBMET01260 0.306 0.005 DBMET01261 | DBMET01261 | |
| 0.321 | 0.14 | 0.41 | Calcium channel L-type activator | 0.41 0.074 DBMET00159 | DBMET00159 | |
| 0.264 | 0.084 | 0.323 | Insulysin inhibitor | 0.323 0.046 DBMET00159 | DBMET00159 | |
| 0.205 | 0.026 | 0.303 | Aldehyde dehydrogenase inhibitor | 0.303 0.011 DBMET00159 0.188 0.031 DBMET01260 0.224 0.023 DBMET01261 | DBMET00159 | |
| 0.201 | 0.024 | 0.252 | 5-Lipoxygenase inhibitor | 0.252 0.015 DBMET00159 | DBMET00159 | |
| 0.207 | 0.031 | 0.235 | Neurotensin receptor agonist | 0.235 0.024 DBMET00159 | DBMET00159 | |
| 0.205 | 0.032 | 0.39 | Hexokinase inhibitor | 0.234 0.021 DBMET00159 0.266 0.014 DBMET01260 0.39 0.005 DBMET01261 | DBMET01261 | |
| 0.177 | 0.005 | 0.177 | Peroxisome proliferator-activated receptor alpha agonist | 0.126 0.008 DBMET00159 0.048 0.034 DBMET01259 0.065 0.024 DBMET01261 | ||
| 0.168 | 0.002 | 0.168 | Melatonin receptor 1A agonist | 0.062 0.005 DBMET00159 | ||
| 0.236 | 0.071 | 0.372 | Cyclic AMP phosphodiesterase inhibitor | 0.232 0.073 DBMET00159 0.299 0.042 DBMET01260 0.372 0.021 DBMET01261 | DBMET01261 | |
| 0.169 | 0.004 | 0.169 | Granulocyte macrophage colony stimulating factor agonist | 0.137 0.008 DBMET00159 | ||
| 0.178 | 0.016 | 0.188 | Sphingosine 1-phosphate receptor 2 antagonist | 0.188 0.011 DBMET00159 0.121 0.094 DBMET01259 | DBMET00159 | |
| 0.202 | 0.04 | 0.382 | Interferon gamma antagonist | 0.241 0.03 DBMET00159 0.184 0.048 DBMET00160 0.369 0.013 DBMET01260 0.382 0.012 DBMET01261 | DBMET01261 | |
| 0.203 | 0.042 | 0.355 | Phospholipase C inhibitor | 0.324 0.016 DBMET00159 0.355 0.014 DBMET01259 0.214 0.036 DBMET01260 0.217 0.035 DBMET01261 | DBMET01259 | |
| 0.169 | 0.008 | 0.169 | Leukotriene antagonist | 0.163 0.009 DBMET00159 0.06 0.05 DBMET00160 0.131 0.013 DBMET01259 0.101 0.021 DBMET01260 0.129 0.013 DBMET01261 | ||
| 0.238 | 0.078 | 0.391 | Platelet antagonist | 0.253 0.071 DBMET00159 0.277 0.061 DBMET00160 0.285 0.058 DBMET01259 0.366 0.034 DBMET01260 0.391 0.029 DBMET01261 | DBMET01261 | |
| 0.172 | 0.015 | 0.242 | Prolactin inhibitor | 0.242 0.005 DBMET00159 | DBMET00159 | |
| 0.174 | 0.02 | 0.252 | Photosensitizer | 0.184 0.017 DBMET00159 0.124 0.052 DBMET00160 0.101 0.087 DBMET01259 0.204 0.012 DBMET01260 0.252 0.006 DBMET01261 | DBMET01261 | |
| 0.165 | 0.012 | 0.221 | Keratolytic | 0.221 0.007 DBMET00159 | DBMET00159 | |
| 0.26 | 0.108 | 0.497 | Interleukin 2 agonist | 0.338 0.051 DBMET00159 0.307 0.069 DBMET00160 0.497 0.008 DBMET01260 0.455 0.015 DBMET01261 | DBMET01260 | |
| 0.172 | 0.021 | 0.512 | Mediator release inhibitor | 0.217 0.012 DBMET00159 0.415 0.005 DBMET01260 0.512 0.004 DBMET01261 | DBMET01261 | |
| 0.162 | 0.012 | 0.203 | Macrophage migration inhibitory factor inhibitor | 0.203 0.008 DBMET00159 | DBMET00159 | |
| 0.185 | 0.039 | 0.197 | Mannose-6-phosphate isomerase inhibitor | 0.187 0.038 DBMET00159 0.197 0.032 DBMET01260 0.194 0.034 DBMET01261 | DBMET01260 | |
| 0.161 | 0.016 | 0.237 | DOPA decarboxylase inhibitor | 0.237 0.004 DBMET00159 0.101 0.075 DBMET01259 | DBMET00159 | |
| 0.153 | 0.009 | 0.153 | Glutamate release inhibitor | 0.124 0.02 DBMET00159 0.085 0.074 DBMET00160 0.139 0.013 DBMET01260 0.13 0.016 DBMET01261 | ||
| 0.205 | 0.062 | 0.49 | Hepatoprotectant | 0.231 0.05 DBMET00159 0.227 0.051 DBMET00160 0.253 0.042 DBMET01259 0.451 0.01 DBMET01260 0.49 0.007 DBMET01261 | DBMET01261 | |
| 0.164 | 0.023 | 0.206 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.167 0.022 DBMET00159 0.103 0.051 DBMET00160 0.159 0.024 DBMET01260 0.206 0.015 DBMET01261 | DBMET01261 | |
| 0.153 | 0.012 | 0.153 | Peroxisome proliferator-activated receptor gamma agonist | 0.144 0.014 DBMET00159 0.091 0.033 DBMET01261 | ||
| 0.156 | 0.017 | 0.186 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.186 0.011 DBMET00159 | DBMET00159 | |
| 0.142 | 0.005 | 0.17 | Estrogen-related receptor beta agonist | 0.17 0.003 DBMET00159 0.08 0.066 DBMET01259 0.082 0.062 DBMET01260 | DBMET00159 | |
| 0.16 | 0.025 | 0.243 | GABA C receptor antagonist | 0.243 0.007 DBMET00159 0.165 0.023 DBMET01259 | DBMET00159 | |
| 0.207 | 0.077 | 0.223 | Nitric-oxide synthase stimulant | 0.223 0.056 DBMET00159 0.206 0.079 DBMET01260 0.223 0.057 DBMET01261 | DBMET01261 | |
| 0.219 | 0.089 | 0.219 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.208 0.095 DBMET00159 | ||
| 0.129 | 0.004 | 0.136 | DNA helicase inhibitor | 0.136 0.003 DBMET00159 0.068 0.019 DBMET00160 0.102 0.005 DBMET01259 0.071 0.016 DBMET01260 0.092 0.007 DBMET01261 | DBMET00159 | |
| 0.14 | 0.015 | 0.162 | Ornithine decarboxylase inhibitor | 0.162 0.008 DBMET00159 0.093 0.052 DBMET00160 0.093 0.052 DBMET01259 0.101 0.043 DBMET01260 0.123 0.024 DBMET01261 | DBMET00159 | |
| 0.146 | 0.024 | 0.146 | Folate antagonist | 0.141 0.026 DBMET00159 0.105 0.057 DBMET01260 0.124 0.036 DBMET01261 | ||
| 0.127 | 0.004 | 0.127 | Peroxisome proliferator-activated receptor delta agonist | 0.075 0.008 DBMET00159 | ||
| 0.161 | 0.041 | 0.341 | Alkylator | 0.179 0.033 DBMET00159 0.136 0.055 DBMET01259 0.341 0.01 DBMET01260 0.333 0.011 DBMET01261 | DBMET01260 | |
| 0.155 | 0.036 | 0.165 | Heat shock protein 70 antagonist | 0.164 0.023 DBMET00159 0.148 0.05 DBMET01260 0.165 0.022 DBMET01261 | DBMET01261 | |
| 0.119 | 0.004 | 0.13 | Retinoid X alpha receptor agonist | 0.13 0.004 DBMET00159 0.036 0.023 DBMET01259 | DBMET00159 | |
| 0.159 | 0.045 | 0.267 | DNA polymerase I inhibitor | 0.207 0.026 DBMET00159 0.267 0.014 DBMET00160 0.11 0.077 DBMET01259 0.202 0.027 DBMET01260 0.2 0.028 DBMET01261 | DBMET00160 | |
| 0.152 | 0.039 | 0.251 | Beta amyloid protein antagonist | 0.12 0.067 DBMET00159 0.122 0.066 DBMET00160 0.251 0.008 DBMET01260 0.161 0.033 DBMET01261 | DBMET01260 | |
| 0.151 | 0.039 | 0.171 | Ca2+-transporting ATPase inhibitor | 0.164 0.019 DBMET00159 0.15 0.042 DBMET00160 0.171 0.012 DBMET01260 0.156 0.03 DBMET01261 | DBMET01260 | |
| 0.205 | 0.093 | 0.313 | RNA-directed DNA polymerase inhibitor | 0.238 0.057 DBMET00159 0.313 0.029 DBMET01259 0.204 0.094 DBMET01260 0.199 0.101 DBMET01261 | DBMET01259 | |
| 0.115 | 0.004 | 0.115 | Calcium channel P-type blocker | 0.07 0.028 DBMET00159 | ||
| 0.115 | 0.005 | 0.135 | Liver X receptor beta agonist | 0.135 0.004 DBMET00159 | DBMET00159 | |
| 0.115 | 0.005 | 0.195 | CXC chemokine 1 receptor antagonist | 0.195 0.004 DBMET00159 0.101 0.005 DBMET01259 0.053 0.032 DBMET01261 | DBMET00159 | |
| 0.138 | 0.029 | 0.215 | Catalase inhibitor | 0.162 0.023 DBMET00159 0.215 0.013 DBMET01259 | DBMET01259 | |
| 0.113 | 0.004 | 0.113 | Peroxisome proliferator-activated receptor alpha antagonist | 0.09 0.005 DBMET00159 0.018 0.016 DBMET01259 | ||
| 0.134 | 0.025 | 0.571 | Triose-phosphate isomerase inhibitor | 0.202 0.011 DBMET00159 0.08 0.076 DBMET00160 0.571 0.002 DBMET01259 0.281 0.005 DBMET01260 0.346 0.004 DBMET01261 | DBMET01259 | |
| 0.112 | 0.006 | 0.112 | Glutamate (mGluR7) antagonist | 0.095 0.014 DBMET00159 | ||
| 0.132 | 0.026 | 0.14 | Interleukin 1 beta converting enzyme inhibitor | 0.14 0.022 DBMET00159 | DBMET00159 | |
| 0.106 | 0.004 | 0.106 | Ryanodine receptor antagonist | 0.078 0.01 DBMET00159 | ||
| 0.121 | 0.02 | 0.121 | Purinergic P2X2 antagonist | 0.112 0.024 DBMET00159 0.08 0.04 DBMET01259 | ||
| 0.13 | 0.029 | 0.273 | Alcohol dehydrogenase inhibitor | 0.273 0.006 DBMET00159 0.081 0.078 DBMET01259 0.115 0.039 DBMET01260 0.163 0.017 DBMET01261 | DBMET00159 | |
| 0.115 | 0.015 | 0.172 | Aldose reductase inhibitor | 0.172 0.009 DBMET00159 0.151 0.011 DBMET01259 0.081 0.023 DBMET01260 0.156 0.01 DBMET01261 | DBMET00159 | |
| 0.129 | 0.029 | 0.129 | Phosphodiesterase IV inhibitor | |||
| 0.155 | 0.055 | 0.187 | Adenylate cyclase stimulant | 0.187 0.021 DBMET00159 0.169 0.037 DBMET01259 0.14 0.081 DBMET01260 0.129 0.104 DBMET01261 | DBMET00159 | |
| 0.181 | 0.082 | 0.478 | Platelet adhesion inhibitor | 0.192 0.075 DBMET00159 0.255 0.048 DBMET00160 0.4 0.011 DBMET01259 0.478 0.006 DBMET01260 0.432 0.009 DBMET01261 | DBMET01260 | |
| 0.103 | 0.004 | 0.111 | Retinoid X receptor agonist | 0.111 0.004 DBMET00159 0.03 0.029 DBMET01259 | DBMET00159 | |
| 0.171 | 0.073 | 0.171 | 3C-like protease (Human coronavirus) inhibitor | 0.146 0.108 DBMET00159 | ||
| 0.172 | 0.074 | 0.172 | Tumour necrosis factor antagonist | |||
| 0.151 | 0.053 | 0.165 | NADPH oxidase inhibitor | 0.165 0.046 DBMET00159 0.126 0.076 DBMET01261 | DBMET00159 | |
| 0.131 | 0.034 | 0.131 | Electron transport complex I inhibitor | |||
| 0.13 | 0.035 | 0.184 | Potassium channel (Ca-activated) activator | 0.184 0.018 DBMET00159 | DBMET00159 | |
| 0.123 | 0.028 | 0.123 | Glutamate (mGluR7) agonist | 0.089 0.088 DBMET00159 | ||
| 0.111 | 0.016 | 0.124 | Glycine receptor agonist | 0.124 0.011 DBMET00159 0.084 0.034 DBMET00160 0.069 0.058 DBMET01259 0.098 0.022 DBMET01260 0.098 0.022 DBMET01261 | DBMET00159 | |
| 0.147 | 0.055 | 0.188 | Farnesoid X receptor antagonist | 0.188 0.026 DBMET00159 | DBMET00159 | |
| 0.182 | 0.092 | 0.212 | Pyruvate kinase inhibitor | 0.212 0.075 DBMET00159 | DBMET00159 | |
| 0.114 | 0.025 | 0.135 | ATPase (Vacuolar H+) inhibitor | 0.105 0.033 DBMET00159 0.117 0.022 DBMET00160 0.117 0.022 DBMET01260 0.135 0.012 DBMET01261 | DBMET01261 | |
| 0.159 | 0.07 | 0.408 | Protein-tyrosine phosphatase inhibitor | 0.205 0.045 DBMET00159 0.154 0.074 DBMET00160 0.408 0.008 DBMET01259 0.165 0.066 DBMET01260 0.174 0.06 DBMET01261 | DBMET01259 | |
| 0.119 | 0.031 | 0.158 | Thioredoxin inhibitor | 0.135 0.022 DBMET00159 0.091 0.061 DBMET01259 0.13 0.025 DBMET01260 0.158 0.015 DBMET01261 | DBMET01261 | |
| 0.111 | 0.024 | 0.125 | Vanilloid agonist | 0.125 0.016 DBMET00159 0.099 0.034 DBMET01259 0.09 0.047 DBMET01260 0.086 0.055 DBMET01261 | DBMET00159 | |
| 0.135 | 0.049 | 0.135 | Sphingosine 1-phosphate receptor 4 antagonist | 0.129 0.057 DBMET00159 | ||
| 0.106 | 0.02 | 0.202 | T cell inhibitor | 0.108 0.019 DBMET00159 0.202 0.007 DBMET00160 0.117 0.015 DBMET01260 0.137 0.011 DBMET01261 | DBMET00160 | |
| 0.108 | 0.022 | 0.114 | Leukotriene synthesis inhibitor | 0.114 0.019 DBMET00159 | DBMET00159 | |
| 0.089 | 0.003 | 0.089 | Free fatty acid receptor 1 antagonist | 0.066 0.005 DBMET00159 | ||
| 0.137 | 0.052 | 0.268 | Protein-tyrosine phosphatase 1B inhibitor | 0.181 0.034 DBMET00159 0.148 0.046 DBMET00160 0.268 0.014 DBMET01259 0.164 0.04 DBMET01260 0.176 0.036 DBMET01261 | DBMET01259 | |
| 0.129 | 0.044 | 0.231 | GABA C receptor agonist | 0.231 0.016 DBMET00159 | DBMET00159 | |
| 0.145 | 0.062 | 0.157 | Pregnane X receptor agonist | 0.157 0.041 DBMET00159 0.128 0.107 DBMET01259 | DBMET00159 | |
| 0.092 | 0.01 | 0.092 | Oleamide hydrolase inhibitor | 0.085 0.012 DBMET00159 | ||
| 0.131 | 0.05 | 0.178 | Microtubule formation inhibitor | 0.12 0.061 DBMET00159 0.112 0.071 DBMET00160 0.178 0.026 DBMET01260 0.155 0.035 DBMET01261 | DBMET01260 | |
| 0.116 | 0.037 | 0.116 | Calcium antagonist | |||
| 0.102 | 0.023 | 0.102 | Amidase inhibitor | 0.102 0.023 DBMET00159 | ||
| 0.122 | 0.043 | 0.135 | Urease inhibitor | 0.135 0.032 DBMET00159 | DBMET00159 | |
| 0.104 | 0.025 | 0.122 | D-Ala-D-Ala ligase inhibitor | 0.122 0.012 DBMET00159 | DBMET00159 | |
| 0.128 | 0.049 | 0.131 | Caspase 3 inhibitor | 0.131 0.045 DBMET00159 | DBMET00159 | |
| 0.103 | 0.025 | 0.146 | GABA aminotransferase inhibitor | 0.146 0.008 DBMET00159 0.138 0.01 DBMET01260 0.112 0.02 DBMET01261 | DBMET00159 | |
| 0.252 | 0.175 | 0.653 | Antibacterial | 0.342 0.107 DBMET00159 0.592 0.02 DBMET00160 0.472 0.049 DBMET01259 0.653 0.013 DBMET01260 0.652 0.013 DBMET01261 | DBMET01260 | |
| 0.181 | 0.105 | 0.736 | Angiogenesis stimulant | 0.24 0.075 DBMET00159 0.348 0.033 DBMET00160 0.463 0.014 DBMET01259 0.686 0.005 DBMET01260 0.736 0.004 DBMET01261 | DBMET01261 | |
| 0.079 | 0.004 | 0.115 | Liver X receptor beta antagonist | 0.115 0.003 DBMET00159 | DBMET00159 | |
| 0.093 | 0.02 | 0.297 | Alcohol oxidase inhibitor | 0.297 0.004 DBMET00159 | DBMET00159 | |
| 0.108 | 0.036 | 0.274 | NADH dehydrogenase inhibitor | 0.135 0.022 DBMET00159 0.088 0.06 DBMET01259 0.274 0.007 DBMET01260 0.225 0.009 DBMET01261 | DBMET01260 | |
| 0.074 | 0.005 | 0.074 | Melatonin 2 agonist | 0.044 0.013 DBMET00159 0.036 0.02 DBMET01261 | ||
| 0.118 | 0.048 | 0.134 | Carbonic anhydrase XV inhibitor | 0.134 0.038 DBMET00159 | DBMET00159 | |
| 0.085 | 0.018 | 0.104 | Nitric oxide donor | 0.086 0.017 DBMET00159 0.087 0.017 DBMET00160 0.104 0.007 DBMET01260 0.097 0.01 DBMET01261 | DBMET01260 | |
| 0.115 | 0.049 | 0.181 | Toll-Like receptor 4 antagonist | 0.121 0.043 DBMET00159 0.13 0.034 DBMET00160 0.181 0.009 DBMET01260 0.174 0.011 DBMET01261 | DBMET01260 | |
| 0.214 | 0.148 | 0.564 | Immunomodulator | 0.292 0.087 DBMET00159 0.224 0.138 DBMET01259 0.465 0.029 DBMET01260 0.564 0.015 DBMET01261 | DBMET01261 | |
| 0.083 | 0.021 | 0.089 | Glutamate (mGluR6) antagonist | 0.089 0.016 DBMET00159 | DBMET00159 | |
| 0.091 | 0.029 | 0.116 | Sphingosine 1-phosphate receptor antagonist | 0.116 0.014 DBMET00159 | DBMET00159 | |
| 0.066 | 0.004 | 0.071 | Retinoid X receptor antagonist | 0.071 0.004 DBMET00159 0.038 0.026 DBMET01259 | DBMET00159 | |
| 0.144 | 0.082 | 0.163 | GABA C receptor rho-2 antagonist | 0.163 0.058 DBMET00159 | DBMET00159 | |
| 0.155 | 0.094 | 0.178 | Catenin beta inhibitor | 0.178 0.055 DBMET00159 | DBMET00159 | |
| 0.07 | 0.009 | 0.07 | Glutamate (mGluR group III) antagonist | 0.066 0.01 DBMET00159 | ||
| 0.131 | 0.07 | 0.131 | Tubulin antagonist | |||
| 0.076 | 0.017 | 0.102 | Leukotriene B4 antagonist | 0.074 0.018 DBMET00159 0.091 0.012 DBMET01259 0.071 0.019 DBMET01260 0.102 0.01 DBMET01261 | DBMET01261 | |
| 0.115 | 0.057 | 0.128 | Acetylcholine release stimulant | 0.128 0.037 DBMET01259 0.11 0.066 DBMET01260 0.103 0.08 DBMET01261 | DBMET01259 | |
| 0.072 | 0.014 | 0.116 | CD45 antagonist | 0.116 0.008 DBMET00159 | DBMET00159 | |
| 0.16 | 0.102 | 0.184 | P-glycoprotein inhibitor | 0.15 0.117 DBMET00160 0.184 0.076 DBMET01260 0.149 0.118 DBMET01261 | DBMET01260 | |
| 0.096 | 0.04 | 0.316 | Carbonic anhydrase XIII inhibitor | 0.113 0.032 DBMET00159 0.316 0.005 DBMET01259 0.087 0.045 DBMET01260 0.099 0.038 DBMET01261 | DBMET01259 | |
| 0.067 | 0.011 | 0.095 | AICAR transformylase inhibitor | 0.095 0.005 DBMET00159 0.085 0.006 DBMET01259 | DBMET00159 | |
| 0.109 | 0.053 | 0.109 | Bronchodilator | 0.103 0.061 DBMET00159 | ||
| 0.108 | 0.052 | 0.252 | Creatine kinase inhibitor | 0.252 0.005 DBMET00159 0.111 0.048 DBMET01259 | DBMET00159 | |
| 0.108 | 0.052 | 0.152 | Anabolic | 0.142 0.022 DBMET00159 0.152 0.017 DBMET01259 0.087 0.084 DBMET01260 | DBMET01259 | |
| 0.079 | 0.023 | 0.079 | Prostaglandin antagonist | 0.073 0.025 DBMET00159 | ||
| 0.09 | 0.035 | 0.139 | Estrogen receptor alpha antagonist | 0.139 0.013 DBMET00159 | DBMET00159 | |
| 0.067 | 0.012 | 0.067 | Cholesterol esterase inhibitor | 0.067 0.012 DBMET00159 | ||
| 0.072 | 0.018 | 0.089 | Aconitate hydratase inhibitor | 0.089 0.011 DBMET00159 | DBMET00159 | |
| 0.104 | 0.05 | 0.128 | Lanosterol 14 alpha demethylase inhibitor | 0.128 0.023 DBMET00159 | DBMET00159 | |
| 0.056 | 0.004 | 0.059 | Retinoid X alpha receptor antagonist | 0.059 0.004 DBMET00159 0.033 0.025 DBMET01259 | DBMET00159 | |
| 0.125 | 0.074 | 0.125 | Antibacterial (Helicobacter pylori) | 0.125 0.074 DBMET00159 0.118 0.084 DBMET01259 0.116 0.087 DBMET01260 | ||
| 0.094 | 0.043 | 0.105 | Glutathione S-transferase inhibitor | 0.105 0.033 DBMET00159 | DBMET00159 | |
| 0.133 | 0.082 | 0.373 | Cell wall synthesis inhibitor | 0.191 0.034 DBMET00159 0.156 0.06 DBMET00160 0.345 0.008 DBMET01259 0.373 0.007 DBMET01260 0.357 0.008 DBMET01261 | DBMET01260 | |
| 0.079 | 0.028 | 0.111 | Aromatase inhibitor | 0.111 0.019 DBMET00159 0.07 0.034 DBMET01259 | DBMET00159 | |
| 0.059 | 0.008 | 0.075 | Glucagon receptor antagonist | 0.075 0.005 DBMET00159 | DBMET00159 | |
| 0.115 | 0.064 | 0.211 | Estrogen antagonist | 0.211 0.012 DBMET00159 0.126 0.045 DBMET01260 0.102 0.094 DBMET01261 | DBMET00159 | |
| 0.106 | 0.056 | 0.155 | Carbonic anhydrase III inhibitor | 0.155 0.026 DBMET00159 0.133 0.036 DBMET01259 0.091 0.074 DBMET01260 | DBMET00159 | |
| 0.065 | 0.016 | 0.212 | Heparanase inhibitor | 0.06 0.024 DBMET00159 0.058 0.026 DBMET00160 0.093 0.004 DBMET01259 0.129 0.003 DBMET01260 0.212 0.002 DBMET01261 | DBMET01261 | |
| 0.065 | 0.016 | 0.065 | Macrophage elastase inhibitor | 0.065 0.016 DBMET00159 | ||
| 0.147 | 0.098 | 0.183 | Antipruritic | 0.183 0.062 DBMET00159 | DBMET00159 | |
| 0.057 | 0.009 | 0.058 | Glutamate (mGluR3) antagonist | 0.058 0.009 DBMET00159 | DBMET00159 | |
| 0.086 | 0.038 | 0.181 | Histidine decarboxylase inhibitor | 0.181 0.015 DBMET00159 | DBMET00159 | |
| 0.075 | 0.028 | 0.075 | Collagenase 3 inhibitor | |||
| 0.111 | 0.065 | 0.111 | GABA receptor agonist | 0.11 0.066 DBMET00159 | ||
| 0.062 | 0.016 | 0.074 | Liver X receptor agonist | 0.074 0.012 DBMET00159 | DBMET00159 | |
| 0.074 | 0.028 | 0.123 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.123 0.011 DBMET00159 0.089 0.021 DBMET01260 0.103 0.016 DBMET01261 | DBMET00159 | |
| 0.068 | 0.022 | 0.094 | Glycine transporter 2 inhibitor | 0.094 0.014 DBMET00159 | DBMET00159 | |
| 0.052 | 0.006 | 0.052 | Cholesterol ester transfer protein antagonist | 0.037 0.016 DBMET00159 0.047 0.009 DBMET01259 | ||
| 0.081 | 0.035 | 0.081 | Phosphodiesterase 4B inhibitor | |||
| 0.066 | 0.02 | 0.073 | Plasminogen activator inhibitor antagonist | 0.073 0.017 DBMET00159 | DBMET00159 | |
| 0.064 | 0.019 | 0.064 | Potassium channel Kv1.3 blocker | 0.045 0.035 DBMET00159 | ||
| 0.105 | 0.06 | 0.138 | Adenylate kinase inhibitor | 0.138 0.031 DBMET00159 0.102 0.064 DBMET01259 0.101 0.066 DBMET01261 | DBMET00159 | |
| 0.14 | 0.095 | 0.155 | CF transmembrane conductance regulator agonist | 0.154 0.07 DBMET00159 0.155 0.067 DBMET01260 | DBMET01260 | |
| 0.066 | 0.021 | 0.076 | Thromboxane synthase inhibitor | 0.076 0.014 DBMET00159 | DBMET00159 | |
| 0.108 | 0.063 | 0.178 | Ferrochelatase inhibitor | 0.178 0.028 DBMET00159 | DBMET00159 | |
| 0.051 | 0.008 | 0.051 | Vanilloid 3 antagonist | 0.04 0.023 DBMET00159 | ||
| 0.088 | 0.046 | 0.088 | Metalloproteinase-2 inhibitor | 0.084 0.048 DBMET00159 | ||
| 0.051 | 0.009 | 0.051 | Melatonin 1 agonist | |||
| 0.063 | 0.021 | 0.126 | Glucose-6-phosphate translocase inhibitor | 0.06 0.023 DBMET00159 0.086 0.009 DBMET00160 0.126 0.004 DBMET01260 0.108 0.005 DBMET01261 | DBMET01260 | |
| 0.117 | 0.076 | 0.125 | MAO inhibitor | 0.125 0.072 DBMET00159 | DBMET00159 | |
| 0.112 | 0.072 | 0.127 | Proteasome inhibitor | 0.127 0.06 DBMET00159 | DBMET00159 | |
| 0.055 | 0.016 | 0.078 | Urate transporter 1 inhibitor | 0.078 0.008 DBMET00159 | DBMET00159 | |
| 0.052 | 0.012 | 0.054 | Kainate receptor agonist | 0.054 0.01 DBMET00159 | DBMET00159 | |
| 0.044 | 0.005 | 0.044 | Free fatty acid receptor 1 agonist | 0.035 0.005 DBMET00159 | ||
| 0.12 | 0.081 | 0.151 | Papain-like protease (SARS coronavirus) inhibitor | 0.151 0.033 DBMET00159 | DBMET00159 | |
| 0.137 | 0.098 | 0.138 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.138 0.097 DBMET00159 | DBMET00159 | |
| 0.056 | 0.017 | 0.081 | 5-Alpha-reductase inhibitor | 0.081 0.012 DBMET00159 | DBMET00159 | |
| 0.044 | 0.005 | 0.083 | Thyroid hormone agonist | 0.076 0.003 DBMET00159 0.083 0.003 DBMET01259 | DBMET01259 | |
| 0.081 | 0.043 | 0.27 | Cathepsin G inhibitor | 0.101 0.033 DBMET00159 0.27 0.011 DBMET01259 | DBMET01259 | |
| 0.122 | 0.084 | 0.151 | Bone formation stimulant | 0.151 0.058 DBMET00159 0.14 0.068 DBMET01260 0.118 0.087 DBMET01261 | DBMET00159 | |
| 0.06 | 0.023 | 0.06 | Lysophosphatidic acid 3 receptor antagonist | 0.049 0.037 DBMET00159 | ||
| 0.082 | 0.046 | 0.082 | Phosphodiesterase 4D inhibitor | |||
| 0.097 | 0.062 | 0.196 | Xanthine oxidase inhibitor | 0.144 0.037 DBMET00159 0.184 0.023 DBMET01260 0.196 0.02 DBMET01261 | DBMET01261 | |
| 0.052 | 0.017 | 0.052 | Dihydrofolate reductase inhibitor | 0.05 0.019 DBMET01259 | ||
| 0.056 | 0.021 | 0.175 | NMDA receptor subunit 3B antagonist | 0.175 0.005 DBMET00159 | DBMET00159 | |
| 0.062 | 0.028 | 0.062 | 5 Hydroxytryptamine 7 agonist | 0.053 0.044 DBMET00159 | ||
| 0.063 | 0.029 | 0.063 | Matrix metalloproteinase (membrane-type) inhibitor | 0.052 0.042 DBMET00159 | ||
| 0.1 | 0.065 | 0.183 | Estrogen receptor beta antagonist | 0.183 0.011 DBMET00159 0.094 0.076 DBMET01260 | DBMET00159 | |
| 0.059 | 0.026 | 0.062 | Immunoglobulin Fc receptor antagonist | 0.062 0.02 DBMET00159 | DBMET00159 | |
| 0.049 | 0.015 | 0.05 | Farnesoid X receptor agonist | 0.042 0.021 DBMET00159 0.05 0.015 DBMET01259 | DBMET01259 | |
| 0.042 | 0.008 | 0.051 | Liver X receptor alpha antagonist | 0.051 0.005 DBMET00159 | DBMET00159 | |
| 0.08 | 0.047 | 0.236 | Porphobilinogen synthase inhibitor | 0.236 0.009 DBMET00159 0.1 0.036 DBMET01259 | DBMET00159 | |
| 0.052 | 0.019 | 0.055 | Guanylate cyclase inhibitor | 0.045 0.027 DBMET00159 0.055 0.016 DBMET01259 0.042 0.031 DBMET01260 0.051 0.02 DBMET01261 | DBMET01259 | |
| 0.058 | 0.027 | 0.062 | Diacylglycerol O-acyltransferase inhibitor | 0.062 0.025 DBMET00159 | DBMET00159 | |
| 0.07 | 0.039 | 0.07 | Neutrophil collagenase inhibitor | 0.067 0.042 DBMET00159 | ||
| 0.042 | 0.011 | 0.083 | ATP citrate lysase inhibitor | 0.083 0.004 DBMET00159 | DBMET00159 | |
| 0.092 | 0.062 | 0.155 | Uric acid excretion stimulant | 0.135 0.029 DBMET00159 0.149 0.024 DBMET01260 0.155 0.021 DBMET01261 | DBMET01261 | |
| 0.043 | 0.013 | 0.043 | Melatonin agonist | |||
| 0.033 | 0.004 | 0.037 | Retinoid X beta receptor antagonist | 0.037 0.003 DBMET00159 0.021 0.014 DBMET01259 | DBMET00159 | |
| 0.072 | 0.043 | 0.072 | Matrix metalloproteinase inhibitor | 0.058 0.057 DBMET00159 | ||
| 0.069 | 0.041 | 0.071 | MDM2 inhibitor | 0.071 0.035 DBMET00159 | DBMET00159 | |
| 0.076 | 0.048 | 0.211 | CDC25A inhibitor | 0.1 0.027 DBMET00159 0.211 0.006 DBMET01259 | DBMET01259 | |
| 0.041 | 0.013 | 0.053 | Liver X receptor antagonist | 0.053 0.009 DBMET00159 | DBMET00159 | |
| 0.032 | 0.005 | 0.032 | G-protein-coupled receptor 120 agonist | 0.019 0.01 DBMET00159 | ||
| 0.049 | 0.022 | 0.062 | Glutamate (mGluR4) antagonist | 0.062 0.013 DBMET00159 | DBMET00159 | |
| 0.075 | 0.049 | 0.155 | Glutamate decarboxylase inhibitor | 0.155 0.012 DBMET00159 0.066 0.06 DBMET01259 | DBMET00159 | |
| 0.058 | 0.032 | 0.062 | Epithelial sodium channel blocker | 0.062 0.026 DBMET00159 | DBMET00159 | |
| 0.04 | 0.014 | 0.04 | Peroxisome proliferator-activated receptor delta antagonist | 0.039 0.015 DBMET00159 | ||
| 0.034 | 0.008 | 0.035 | Retinoid X gamma receptor antagonist | 0.035 0.007 DBMET00159 0.027 0.018 DBMET01259 | DBMET00159 | |
| 0.07 | 0.045 | 0.083 | Sphingosine 1-phosphate receptor 4 agonist | 0.083 0.035 DBMET00159 | DBMET00159 | |
| 0.215 | 0.189 | 0.406 | GABA C receptor rho-3 antagonist | 0.406 0.059 DBMET00159 | DBMET00159 | |
| 0.042 | 0.017 | 0.042 | Prostacyclin antagonist | 0.031 0.025 DBMET00159 | ||
| 0.058 | 0.034 | 0.078 | Thromboxane antagonist | 0.078 0.021 DBMET00159 | DBMET00159 | |
| 0.034 | 0.01 | 0.035 | Prostaglandin H2 antagonist | 0.035 0.009 DBMET00159 | DBMET00159 | |
| 0.033 | 0.009 | 0.033 | Hedgehog signaling activator | 0.028 0.017 DBMET00159 | ||
| 0.179 | 0.155 | 0.352 | DNA synthesis inhibitor | 0.221 0.093 DBMET00159 0.334 0.034 DBMET01260 0.352 0.03 DBMET01261 | DBMET01261 | |
| 0.189 | 0.165 | 0.189 | Thyroid hormone beta antagonist | |||
| 0.028 | 0.005 | 0.072 | Ileal bile acid transport inhibitor | 0.031 0.005 DBMET00159 0.045 0.004 DBMET01260 0.072 0.003 DBMET01261 | DBMET01261 | |
| 0.147 | 0.123 | 0.147 | I kappa B kinase epsilon inhibitor | |||
| 0.092 | 0.07 | 0.106 | MAO A inhibitor | 0.106 0.06 DBMET00159 | DBMET00159 | |
| 0.118 | 0.096 | 0.389 | Lipid peroxidase inhibitor | 0.185 0.048 DBMET00159 0.175 0.053 DBMET00160 0.121 0.093 DBMET01259 0.389 0.01 DBMET01260 0.311 0.017 DBMET01261 | DBMET01260 | |
| 0.06 | 0.038 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | 0.077 0.019 DBMET00159 | DBMET00159 | |
| 0.042 | 0.019 | 0.099 | Nicotinic acid receptor agonist | 0.099 0.005 DBMET00159 | DBMET00159 | |
| 0.043 | 0.021 | 0.13 | AMPA 4 receptor antagonist | 0.13 0.004 DBMET00159 | DBMET00159 | |
| 0.064 | 0.043 | 0.064 | Transcription factor RelA inhibitor | 0.06 0.056 DBMET00159 | ||
| 0.058 | 0.037 | 0.058 | Pregnane X receptor antagonist | 0.056 0.042 DBMET00159 | ||
| 0.036 | 0.015 | 0.043 | Glutamate (mGluR3) agonist | 0.043 0.008 DBMET00159 0.031 0.026 DBMET00160 | DBMET00159 | |
| 0.044 | 0.024 | 0.044 | Acetyl-CoA transferase 1 inhibitor | 0.042 0.028 DBMET00159 | ||
| 0.027 | 0.007 | 0.029 | Calcium-sensing receptor antagonist | 0.029 0.006 DBMET00159 | DBMET00159 | |
| 0.055 | 0.035 | 0.055 | Acetyl-CoA transferase inhibitor | 0.053 0.037 DBMET00159 | ||
| 0.1 | 0.081 | 0.1 | Interleukin 1b antagonist | |||
| 0.088 | 0.068 | 0.093 | MAO B inhibitor | 0.093 0.064 DBMET00159 | DBMET00159 | |
| 0.039 | 0.019 | 0.043 | AMPA receptor agonist | 0.043 0.014 DBMET00159 | DBMET00159 | |
| 0.061 | 0.043 | 0.07 | Heme oxygenase stimulant | 0.07 0.025 DBMET00159 | DBMET00159 | |
| 0.049 | 0.031 | 0.084 | Glucose-6-phosphate isomerase inhibitor | 0.063 0.016 DBMET00159 0.046 0.036 DBMET01259 0.073 0.011 DBMET01260 0.084 0.008 DBMET01261 | DBMET01261 | |
| 0.042 | 0.023 | 0.042 | Glucagon-like peptide 1 receptor antagonist | 0.037 0.035 DBMET00159 | ||
| 0.037 | 0.019 | 0.042 | HMG CoA reductase inhibitor | 0.042 0.013 DBMET00159 0.033 0.026 DBMET01260 0.036 0.021 DBMET01261 | DBMET00159 | |
| 0.058 | 0.04 | 0.081 | Xanthine dehydrogenase inhibitor | 0.081 0.024 DBMET00159 | DBMET00159 | |
| 0.054 | 0.037 | 0.055 | Sphingosine 1-phosphate receptor 5 agonist | 0.055 0.035 DBMET00159 | DBMET00159 | |
| 0.1 | 0.084 | 0.158 | Adenylate cyclase inhibitor | 0.158 0.04 DBMET00159 0.094 0.09 DBMET01260 | DBMET00159 | |
| 0.067 | 0.051 | 0.067 | Exportin-1 inhibitor | |||
| 0.069 | 0.053 | 0.069 | Calcium channel L-type blocker | |||
| 0.039 | 0.024 | 0.043 | Glutamate (mGluR8) agonist | 0.043 0.018 DBMET00159 | DBMET00159 | |
| 0.028 | 0.013 | 0.028 | Prostaglandin D2 antagonist | 0.023 0.015 DBMET00159 | ||
| 0.035 | 0.02 | 0.043 | Estrogen-related receptor alpha antagonist | 0.043 0.016 DBMET00159 | DBMET00159 | |
| 0.021 | 0.006 | 0.028 | Thyroid hormone alpha agonist | 0.028 0.004 DBMET00159 | DBMET00159 | |
| 0.058 | 0.044 | 0.081 | Heat shock protein 90 beta antagonist | 0.081 0.02 DBMET00159 | DBMET00159 | |
| 0.062 | 0.048 | 0.084 | CDC25B inhibitor | 0.084 0.025 DBMET00159 0.059 0.052 DBMET01260 | DBMET00159 | |
| 0.039 | 0.025 | 0.039 | Glutamate (mGluR group II) antagonist | 0.034 0.033 DBMET00159 | ||
| 0.11 | 0.096 | 0.11 | Nav1.2 sodium channel blocker | |||
| 0.029 | 0.016 | 0.049 | Kynurenine 3 monooxygenase inhibitor | 0.049 0.007 DBMET01259 | DBMET01259 | |
| 0.088 | 0.075 | 0.088 | Sphingomyelinase inhibitor | |||
| 0.2 | 0.187 | 0.2 | Calpain 2 inhibitor | 0.2 0.187 DBMET00159 | ||
| 0.042 | 0.029 | 0.042 | Sphingosine 1-phosphate receptor 1 agonist | 0.041 0.031 DBMET00159 | ||
| 0.149 | 0.136 | 0.149 | Aryl hydrocarbon receptor agonist | |||
| 0.055 | 0.043 | 0.06 | Leukotriene C antagonist | 0.06 0.029 DBMET00159 | DBMET00159 | |
| 0.064 | 0.052 | 0.194 | Phosphofructokinase-1 inhibitor | 0.121 0.025 DBMET00159 0.059 0.058 DBMET01259 0.179 0.013 DBMET01260 0.194 0.012 DBMET01261 | DBMET01261 | |
| 0.023 | 0.011 | 0.026 | Retinoic acid alpha receptor antagonist | 0.026 0.009 DBMET00159 | DBMET00159 | |
| 0.069 | 0.057 | 0.069 | Metalloproteinase-9 inhibitor | |||
| 0.068 | 0.056 | 0.112 | Aminopeptidase I inhibitor | 0.112 0.023 DBMET00159 | DBMET00159 | |
| 0.043 | 0.032 | 0.043 | Sphingosine 1-phosphate receptor agonist | 0.04 0.038 DBMET00159 | ||
| 0.138 | 0.127 | 0.166 | Psychostimulant | 0.146 0.119 DBMET00159 0.166 0.103 DBMET01260 0.146 0.12 DBMET01261 | DBMET01260 | |
| 0.084 | 0.073 | 0.088 | Breast cancer-resistant protein inhibitor | 0.088 0.068 DBMET01259 | DBMET01259 | |
| 0.036 | 0.025 | 0.036 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.064 | 0.053 | 0.196 | Phenylalanine 4-hydroxylase inhibitor | 0.196 0.007 DBMET00159 0.068 0.048 DBMET01259 | DBMET00159 | |
| 0.053 | 0.044 | 0.053 | Beta tubulin antagonist | |||
| 0.023 | 0.015 | 0.028 | ICAM 1 antagonist | 0.028 0.008 DBMET00159 | DBMET00159 | |
| 0.028 | 0.019 | 0.028 | Endothelin receptor antagonist | |||
| 0.026 | 0.018 | 0.116 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 DBMET00159 0.104 0.003 DBMET01260 0.116 0.002 DBMET01261 | DBMET01261 | |
| 0.085 | 0.077 | 0.19 | Aminopeptidase B inhibitor | 0.153 0.037 DBMET00159 0.19 0.024 DBMET01259 | DBMET01259 | |
| 0.05 | 0.043 | 0.093 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.093 0.012 DBMET00159 0.053 0.039 DBMET01259 | DBMET00159 | |
| 0.012 | 0.005 | 0.036 | Thyroid hormone beta agonist | 0.036 0.003 DBMET00159 | DBMET00159 | |
| 0.033 | 0.025 | 0.041 | Fumarate hydratase inhibitor | 0.041 0.018 DBMET00159 | DBMET00159 | |
| 0.025 | 0.018 | 0.114 | Sodium/glucose cotransporter inhibitor | 0.027 0.015 DBMET00159 0.097 0.003 DBMET01260 0.114 0.002 DBMET01261 | DBMET01261 | |
| 0.064 | 0.057 | 0.085 | Prostaglandin-E synthase inhibitor | 0.085 0.036 DBMET00159 | DBMET00159 | |
| 0.037 | 0.031 | 0.042 | Retinoic acid alpha receptor agonist | 0.042 0.023 DBMET00159 | DBMET00159 | |
| 0.048 | 0.041 | 0.057 | Factor III inhibitor | 0.05 0.033 DBMET00159 0.054 0.026 DBMET01260 0.057 0.021 DBMET01261 | DBMET01261 | |
| 0.019 | 0.013 | 0.023 | Retinoic acid receptor antagonist | 0.023 0.009 DBMET00159 | DBMET00159 | |
| 0.04 | 0.035 | 0.048 | GABA B receptor antagonist | 0.048 0.021 DBMET00159 | DBMET00159 | |
| 0.067 | 0.061 | 0.107 | Glutamate dehydrogenase inhibitor | 0.107 0.027 DBMET00159 0.068 0.06 DBMET01259 | DBMET00159 | |
| 0.02 | 0.015 | 0.02 | Integrin alpha4beta7 antagonist | |||
| 0.062 | 0.057 | 0.087 | Potassium channel large-conductance Ca-activated activator | 0.087 0.031 DBMET00159 | DBMET00159 | |
| 0.022 | 0.017 | 0.027 | Prostaglandin F2 alpha agonist | 0.027 0.01 DBMET00159 | DBMET00159 | |
| 0.088 | 0.083 | 0.099 | Nav1.1 sodium channel blocker | 0.099 0.067 DBMET00159 | DBMET00159 | |
| 0.037 | 0.032 | 0.048 | Integrin antagonist | 0.048 0.028 DBMET00159 | DBMET00159 | |
| 0.027 | 0.023 | 0.04 | Factor VII inhibitor | 0.04 0.015 DBMET00159 | DBMET00159 | |
| 0.034 | 0.03 | 0.122 | NMDA receptor subunit 3A antagonist | 0.122 0.007 DBMET00159 | DBMET00159 | |
| 0.054 | 0.051 | 0.072 | Lipocortins synthesis agonist | 0.059 0.039 DBMET00159 0.061 0.034 DBMET00160 0.071 0.02 DBMET01260 0.072 0.019 DBMET01261 | DBMET01261 | |
| 0.047 | 0.045 | 0.047 | Alpha tubulin antagonist | |||
| 0.021 | 0.02 | 0.021 | Integrin alpha4 antagonist | |||
| 0.049 | 0.048 | 0.085 | Argininosuccinate synthase inhibitor | 0.085 0.023 DBMET00159 | DBMET00159 | |
| 0.119 | 0.117 | 0.348 | NOS3 expression enhancer | 0.212 0.036 DBMET00159 0.348 0.012 DBMET01260 0.347 0.012 DBMET01261 | DBMET01260 | |
| 0.021 | 0.019 | 0.023 | Retinoid X gamma receptor agonist | 0.023 0.016 DBMET00159 | DBMET00159 | |
| 0.043 | 0.042 | 0.062 | Thromboxane A2 antagonist | 0.062 0.027 DBMET00159 | DBMET00159 | |
| 0.162 | 0.161 | 0.172 | Calpain inhibitor | 0.172 0.146 DBMET00159 | DBMET00159 | |
| 0.056 | 0.056 | 0.06 | Caspase 9 inhibitor | 0.06 0.048 DBMET00159 | DBMET00159 | |
| 0.036 | 0.035 | 0.036 | Aggrecanase 1 inhibitor | 0.036 0.035 DBMET00159 | ||
| 0.014 | 0.013 | 0.025 | Thyroid hormone alpha antagonist | 0.025 0.005 DBMET00159 | DBMET00159 | |
| 0.051 | 0.051 | 0.056 | Prostaglandin EP2 antagonist | 0.056 0.045 DBMET01261 | DBMET01261 | |
| 0.033 | 0.033 | 0.081 | Glutamate (mGluR8) antagonist | 0.036 0.024 DBMET00159 0.081 0.003 DBMET00160 | DBMET00160 | |
| 0.086 | 0.086 | 0.111 | GABA C receptor rho-1 antagonist | 0.111 0.049 DBMET00159 | DBMET00159 | |
| 0.062 | 0.063 | 0.13 | HIV-1 integrase inhibitor | 0.105 0.022 DBMET00159 0.13 0.012 DBMET01259 | DBMET01259 | |
| 0.018 | 0.019 | 0.019 | Retinoid X beta receptor agonist | 0.019 0.018 DBMET00159 | DBMET00159 | |
| 0.039 | 0.04 | 0.049 | Geranyltranstransferase inhibitor | 0.049 0.024 DBMET00159 | DBMET00159 | |
| 0.022 | 0.023 | 0.023 | Leukotriene D4 antagonist | 0.023 0.021 DBMET00159 | DBMET00159 | |
| 0.023 | 0.024 | 0.044 | Lysine carboxypeptidase inhibitor | 0.044 0.009 DBMET00159 | DBMET00159 | |
| 0.02 | 0.022 | 0.023 | Retinoic acid gamma receptor agonist | 0.023 0.014 DBMET00159 | DBMET00159 | |
| 0.013 | 0.015 | 0.017 | Integrin beta6 antagonist | 0.017 0.006 DBMET00159 | DBMET00159 | |
| 0.07 | 0.072 | 0.101 | Carbonic anhydrase VI inhibitor | 0.101 0.039 DBMET00159 0.087 0.049 DBMET01259 | DBMET00159 | |
| 0.017 | 0.02 | 0.019 | Caspase 8 inhibitor | 0.019 0.015 DBMET00159 | DBMET00159 | |
| 0.054 | 0.057 | 0.075 | Transcription factor AP-1 inhibitor | 0.056 0.054 DBMET00159 0.075 0.025 DBMET01260 0.064 0.038 DBMET01261 | DBMET01260 | |
| 0.012 | 0.015 | 0.021 | Egl nine homolog 1 inhibitor | 0.021 0.005 DBMET00159 | DBMET00159 | |
| 0.009 | 0.013 | 0.011 | Retinoic acid beta receptor antagonist | 0.011 0.01 DBMET00159 | DBMET00159 | |
| 0.117 | 0.12 | 0.152 | Heat shock protein 90 antagonist | 0.152 0.073 DBMET00159 | DBMET00159 | |
| 0.01 | 0.013 | 0.011 | Retinoic acid receptor gamma antagonist | 0.011 0.009 DBMET00159 | DBMET00159 | |
| 0.024 | 0.028 | 0.038 | Toll-Like receptor 4 agonist | 0.03 0.012 DBMET00160 0.038 0.005 DBMET01259 0.036 0.006 DBMET01260 0.036 0.006 DBMET01261 | DBMET01259 | |
| 0.026 | 0.03 | 0.029 | Prostaglandin agonist | 0.029 0.024 DBMET00159 | DBMET00159 | |
| 0.005 | 0.009 | 0.008 | Integrin alpha5beta6 antagonist | 0.008 0.004 DBMET00159 | DBMET00159 | |
| 0.014 | 0.019 | 0.023 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.023 0.012 DBMET00159 | DBMET00159 | |
| 0.044 | 0.049 | 0.051 | Squalene epoxidase inhibitor | 0.051 0.033 DBMET00159 0.046 0.042 DBMET01260 | DBMET00159 | |
| 0.016 | 0.022 | 0.033 | Antibiotic Anthracycline-like | 0.033 0.003 DBMET01260 0.028 0.004 DBMET01261 | DBMET01260 | |
| 0.029 | 0.036 | 0.046 | Nicotinic acid receptor 2 agonist | 0.046 0.016 DBMET00159 0.032 0.03 DBMET01260 | DBMET00159 | |
| 0.015 | 0.021 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 DBMET00159 | DBMET00159 | |
| 0.018 | 0.024 | 0.021 | Integrin alphaVbeta3 antagonist | 0.021 0.015 DBMET00159 | DBMET00159 | |
| 0.104 | 0.111 | 0.174 | Interleukin 4 antagonist | 0.152 0.048 DBMET00159 0.174 0.033 DBMET01260 0.14 0.06 DBMET01261 | DBMET01260 | |
| 0.103 | 0.111 | 0.135 | Alkaline phosphatase inhibitor | 0.107 0.105 DBMET00159 0.135 0.072 DBMET01259 0.108 0.102 DBMET01261 | DBMET01259 | |
| 0.047 | 0.054 | 0.273 | HIV-1 integrase (Strand Transfer) inhibitor | 0.09 0.027 DBMET00159 0.273 0.005 DBMET01259 0.054 0.047 DBMET01261 | DBMET01259 | |
| 0.05 | 0.058 | 0.099 | Adenine nucleotide translocase inhibitor | 0.06 0.028 DBMET00159 0.081 0.009 DBMET00160 0.092 0.005 DBMET01259 0.099 0.005 DBMET01260 0.071 0.015 DBMET01261 | DBMET01260 | |
| 0.048 | 0.056 | 0.082 | Biliverdin reductase inhibitor | 0.082 0.025 DBMET00159 | DBMET00159 | |
| 0.049 | 0.057 | 0.078 | Carbamoyl phosphate synthetase inhibitor | 0.078 0.03 DBMET00159 | DBMET00159 | |
| 0.033 | 0.041 | 0.037 | GABA uptake inhibitor | 0.037 0.032 DBMET00159 | DBMET00159 | |
| 0.057 | 0.066 | 0.063 | Beta 3 adrenoreceptor antagonist | 0.063 0.047 DBMET00159 | DBMET00159 | |
| 0.035 | 0.044 | 0.038 | Leukotriene C4 antagonist | 0.038 0.03 DBMET00159 | DBMET00159 | |
| 0.022 | 0.03 | 0.137 | NMDA 2D receptor antagonist | 0.025 0.023 DBMET00159 0.137 0.003 DBMET01259 | DBMET01259 | |
| 0.028 | 0.037 | 0.038 | Carboxypeptidase B inhibitor | 0.035 0.02 DBMET00159 0.038 0.015 DBMET01259 | DBMET01259 | |
| 0.025 | 0.034 | 0.035 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.035 0.019 DBMET00159 | DBMET00159 | |
| 0.037 | 0.047 | 0.266 | Estrogen agonist | 0.143 0.012 DBMET00159 0.049 0.036 DBMET00160 0.266 0.006 DBMET01259 0.1 0.017 DBMET01260 0.077 0.024 DBMET01261 | DBMET01259 | |
| 0.061 | 0.072 | 0.185 | Topoisomerase II alpha inhibitor | 0.099 0.04 DBMET00159 0.161 0.021 DBMET01260 0.185 0.017 DBMET01261 | DBMET01261 | |
| 0.036 | 0.046 | 0.046 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.046 0.021 DBMET00159 | DBMET00159 | |
| 0.013 | 0.023 | 0.016 | Vitamin D receptor agonist | 0.016 0.013 DBMET00159 0.016 0.012 DBMET01260 | DBMET01260 | |
| 0.024 | 0.035 | 0.034 | Estrogen-related receptor gamma antagonist | 0.034 0.01 DBMET00159 | DBMET00159 | |
| 0.017 | 0.027 | 0.022 | Leukotriene B4 receptor 2 antagonist | 0.02 0.019 DBMET00159 0.02 0.018 DBMET01260 0.022 0.016 DBMET01261 | DBMET01261 | |
| 0.015 | 0.025 | 0.024 | Estrogen-related receptor gamma agonist | 0.024 0.006 DBMET00159 | DBMET00159 | |
| 0.048 | 0.059 | 0.055 | Carbonic anhydrase stimulant | 0.055 0.047 DBMET00159 | DBMET00159 | |
| 0.034 | 0.045 | 0.186 | Leukocyte elastase inhibitor | 0.186 0.005 DBMET01259 | DBMET01259 | |
| 0.021 | 0.032 | 0.029 | Nicotinic acid receptor 2 antagonist | 0.029 0.014 DBMET00159 | DBMET00159 | |
| 0.059 | 0.072 | 0.114 | Na+ K+ transporting ATPase inhibitor | 0.087 0.044 DBMET00159 0.093 0.038 DBMET01259 0.111 0.022 DBMET01260 0.114 0.02 DBMET01261 | DBMET01261 | |
| 0.018 | 0.031 | 0.022 | Vitamin D receptor antagonist | 0.022 0.014 DBMET01260 | DBMET01260 | |
| 0.029 | 0.042 | 0.033 | Growth factor receptor-bound protein 2 antagonist | 0.033 0.028 DBMET00159 | DBMET00159 | |
| 0.084 | 0.098 | 0.311 | AMP-activated protein kinase stimulant | 0.106 0.063 DBMET00159 0.257 0.006 DBMET01260 0.311 0.005 DBMET01261 | DBMET01261 | |
| 0.031 | 0.045 | 0.078 | Dopamine D5 agonist | 0.078 0.007 DBMET00159 | DBMET00159 | |
| 0.049 | 0.064 | 0.278 | HIV-1 integrase (3'-Processing) inhibitor | 0.091 0.029 DBMET00159 0.278 0.005 DBMET01259 0.055 0.054 DBMET01260 0.055 0.053 DBMET01261 | DBMET01259 | |
| 0.048 | 0.064 | 0.089 | NMDA 2C receptor antagonist | 0.089 0.02 DBMET00159 0.076 0.028 DBMET01259 | DBMET00159 | |
| 0.03 | 0.047 | 0.047 | Carbonic anhydrase IV inhibitor | 0.047 0.027 DBMET00159 | DBMET00159 | |
| 0.029 | 0.046 | 0.056 | Estradiol 17 beta-dehydrogenase inhibitor | 0.056 0.021 DBMET00159 | DBMET00159 | |
| 0.018 | 0.036 | 0.041 | CXC chemokine 2 receptor antagonist | 0.041 0.008 DBMET00159 | DBMET00159 | |
| 0.084 | 0.102 | 0.371 | Beta glucuronidase inhibitor | 0.106 0.061 DBMET00159 0.371 0.004 DBMET01260 0.253 0.008 DBMET01261 | DBMET01260 | |
| 0.052 | 0.071 | 0.056 | Bcl-xL inhibitor | 0.056 0.054 DBMET00159 | DBMET00159 | |
| 0.04 | 0.058 | 0.06 | Topoisomerase II beta inhibitor | 0.06 0.022 DBMET00159 | DBMET00159 | |
| 0.077 | 0.096 | 0.373 | UDP-glucose 4-epimerase inhibitor | 0.128 0.038 DBMET00159 0.373 0.007 DBMET01260 0.274 0.012 DBMET01261 | DBMET01260 | |
| 0.036 | 0.055 | 0.086 | Carbonic anhydrase XIV inhibitor | 0.086 0.015 DBMET01260 0.06 0.025 DBMET01261 | DBMET01260 | |
| 0.011 | 0.03 | 0.031 | Nicotinic acid receptor 1 antagonist | 0.031 0.004 DBMET00159 | DBMET00159 | |
| 0.102 | 0.122 | 0.188 | DNA repair enzyme inhibitor | 0.182 0.013 DBMET01260 0.188 0.011 DBMET01261 | DBMET01261 | |
| 0.034 | 0.054 | 0.101 | NMDA 2A receptor antagonist | 0.101 0.013 DBMET00159 0.05 0.038 DBMET01259 | DBMET00159 | |
| 0.112 | 0.134 | 0.152 | Growth hormone agonist | 0.152 0.086 DBMET00159 | DBMET00159 | |
| 0.064 | 0.088 | 0.135 | Glycine receptor antagonist | 0.084 0.051 DBMET00159 0.135 0.011 DBMET01259 0.106 0.027 DBMET01260 0.131 0.013 DBMET01261 | DBMET01259 | |
| 0.106 | 0.131 | 0.574 | Anticoagulant | 0.126 0.105 DBMET00159 0.156 0.075 DBMET00160 0.574 0.007 DBMET01259 0.225 0.045 DBMET01260 0.294 0.029 DBMET01261 | DBMET01259 | |
| 0.058 | 0.083 | 0.092 | Phospholipase D inhibitor | 0.078 0.038 DBMET00159 0.092 0.02 DBMET01259 | DBMET01259 | |
| 0.046 | 0.071 | 0.055 | Sphingosine 1-phosphate receptor 1 antagonist | 0.055 0.039 DBMET00159 | DBMET00159 | |
| 0.037 | 0.064 | 0.06 | Acyl-CoA dehydrogenase inhibitor | 0.06 0.033 DBMET00159 | DBMET00159 | |
| 0.046 | 0.074 | 0.066 | Purinergic P2X1 antagonist | 0.066 0.036 DBMET00159 | DBMET00159 | |
| 0.04 | 0.069 | 0.126 | Elastase inhibitor | 0.126 0.005 DBMET01259 | DBMET01259 | |
| 0.011 | 0.041 | 0.021 | Telomerase stimulant | 0.02 0.008 DBMET01260 0.021 0.007 DBMET01261 | DBMET01261 | |
| 0.024 | 0.057 | 0.042 | Estrogen-related receptor beta antagonist | 0.042 0.009 DBMET00159 | DBMET00159 | |
| 0.073 | 0.107 | 0.117 | Protein kinase C zeta inhibitor | 0.095 0.057 DBMET00159 0.117 0.035 DBMET01259 | DBMET01259 | |
| 0.046 | 0.081 | 0.095 | NMDA receptor agonist | 0.063 0.043 DBMET00159 0.095 0.021 DBMET01259 | DBMET01259 | |
| 0.017 | 0.052 | 0.026 | Protocollagen prolyl hydroxylase inhibitor | 0.026 0.021 DBMET00159 | DBMET00159 | |
| 0.033 | 0.069 | 0.12 | Protein 50S ribosomal subunit inhibitor | 0.12 0.009 DBMET00160 0.095 0.014 DBMET01260 0.112 0.011 DBMET01261 | DBMET00160 | |
| 0.01 | 0.047 | 0.021 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.021 0.017 DBMET00159 | DBMET00159 | |
| 0.11 | 0.147 | 0.149 | Heat shock protein 90 alpha antagonist | 0.149 0.088 DBMET00159 | DBMET00159 | |
| 0.041 | 0.078 | 0.068 | Androgen agonist | 0.068 0.033 DBMET00159 0.053 0.051 DBMET01259 | DBMET00159 | |
| 0.042 | 0.08 | 0.059 | Dihydroorotate oxidase inhibitor | 0.059 0.031 DBMET00159 | DBMET00159 | |
| 0.012 | 0.05 | 0.049 | Glutamate (mGluR1a) agonist | 0.02 0.019 DBMET00159 0.049 0.005 DBMET01259 | DBMET01259 | |
| 0.038 | 0.077 | 0.089 | Alpha-mannosidase inhibitor | 0.058 0.03 DBMET01259 0.069 0.017 DBMET01260 0.089 0.008 DBMET01261 | DBMET01261 | |
| 0.132 | 0.172 | 0.484 | Immunostimulant | 0.212 0.113 DBMET00159 0.284 0.083 DBMET01259 0.484 0.031 DBMET01260 0.481 0.031 DBMET01261 | DBMET01260 | |
| 0.041 | 0.082 | 0.059 | Botulinum neurotoxin type A inhibitor | 0.059 0.039 DBMET00159 | DBMET00159 | |
| 0.018 | 0.06 | 0.03 | Calcitonin receptor agonist | 0.03 0.027 DBMET00159 | DBMET00159 | |
| 0.017 | 0.059 | 0.038 | Vanilloid 2 agonist | 0.024 0.021 DBMET00159 0.032 0.008 DBMET01260 0.038 0.004 DBMET01261 | DBMET01261 | |
| 0.038 | 0.081 | 0.063 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.055 0.041 DBMET00159 0.054 0.042 DBMET01260 0.063 0.032 DBMET01261 | DBMET01261 | |
| 0.024 | 0.067 | 0.038 | Erythropoietin receptor agonist | 0.038 0.03 DBMET00159 | DBMET00159 | |
| 0.044 | 0.088 | 0.058 | Prostaglandin F2 alpha antagonist | 0.058 0.05 DBMET00159 | DBMET00159 | |
| 0.065 | 0.109 | 0.092 | MAP kinase kinase 7 inhibitor | 0.092 0.021 DBMET00159 | DBMET00159 | |
| 0.135 | 0.18 | 0.417 | Tumour necrosis factor alpha release inhibitor | 0.186 0.122 DBMET00160 0.417 0.024 DBMET01260 0.38 0.03 DBMET01261 | DBMET01260 | |
| 0.035 | 0.082 | 0.05 | Dopamine beta hydroxylase inhibitor | 0.05 0.03 DBMET00159 | DBMET00159 | |
| 0.072 | 0.119 | 0.093 | Electrolyte absorption antagonist | 0.093 0.068 DBMET00159 | DBMET00159 | |
| 0.01 | 0.06 | 0.058 | Squalene synthetase inhibitor | 0.058 0.012 DBMET00160 0.032 0.022 DBMET01260 0.043 0.017 DBMET01261 | DBMET00160 | |
| 0.07 | 0.124 | 0.242 | Topoisomerase II inhibitor | 0.115 0.072 DBMET00159 0.206 0.032 DBMET01260 0.242 0.026 DBMET01261 | DBMET01261 | |
| 0.008 | 0.062 | 0.075 | Estrogen receptor alpha agonist | 0.075 0.013 DBMET00159 | DBMET00159 | |
| 0.008 | 0.063 | 0.116 | Estrogen receptor beta agonist | 0.099 0.012 DBMET00159 0.116 0.01 DBMET01259 0.063 0.017 DBMET01260 | DBMET01259 | |
| 0.037 | 0.091 | 0.05 | Sphingosine kinase 2 inhibitor | 0.05 0.048 DBMET00159 | DBMET00159 | |
| 0.041 | 0.096 | 0.212 | Antineoplastic antibiotic | 0.106 0.044 DBMET00160 0.212 0.019 DBMET01260 0.207 0.02 DBMET01261 | DBMET01260 | |
| 0.012 | 0.067 | 0.037 | AMPA 3 receptor antagonist | 0.037 0.015 DBMET00159 | DBMET00159 | |
| 0.051 | 0.107 | 0.063 | Beta 2 adrenoreceptor agonist | 0.063 0.039 DBMET00159 | DBMET00159 | |
| 0.025 | 0.085 | 0.083 | Mannosidase inhibitor | 0.045 0.031 DBMET01259 0.061 0.016 DBMET01260 0.083 0.008 DBMET01261 | DBMET01261 | |
| 0.041 | 0.102 | 0.144 | Carbonic anhydrase VA inhibitor | 0.144 0.012 DBMET01259 | DBMET01259 | |
| 0.01 | 0.072 | 0.057 | Arginase inhibitor | 0.036 0.025 DBMET00159 0.047 0.017 DBMET01260 0.057 0.011 DBMET01261 | DBMET01261 | |
| 0.035 | 0.097 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.036 DBMET00159 | DBMET00159 | |
| 0.002 | 0.064 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 DBMET01261 | DBMET01261 | |
| 0.01 | 0.072 | 0.021 | Corticosteroid-like | 0.021 0.015 DBMET01260 0.019 0.018 DBMET01261 | DBMET01260 | |
| 0.02 | 0.085 | 0.06 | Purinergic P2Y2 antagonist | 0.06 0.008 DBMET01259 | DBMET01259 | |
| 0.016 | 0.082 | 0.033 | Catechol O-methyltransferase inhibitor | 0.033 0.022 DBMET00159 | DBMET00159 | |
| 0.067 | 0.134 | 0.094 | CC chemokine 5 receptor agonist | 0.094 0.029 DBMET00159 0.083 0.055 DBMET01259 | DBMET00159 | |
| 0.073 | 0.141 | 0.119 | Phosphodiesterase 6D inhibitor | 0.11 0.036 DBMET01260 0.119 0.026 DBMET01261 | DBMET01261 | |
| 0.052 | 0.121 | 0.079 | Interferon agonist | 0.079 0.054 DBMET01261 | DBMET01261 | |
| 0.032 | 0.101 | 0.119 | Factor IXa inhibitor | 0.119 0.006 DBMET01259 0.099 0.01 DBMET01260 0.104 0.009 DBMET01261 | DBMET01259 | |
| 0.056 | 0.128 | 0.295 | Topoisomerase I inhibitor | 0.088 0.081 DBMET00159 0.099 0.071 DBMET00160 0.295 0.011 DBMET01260 0.224 0.021 DBMET01261 | DBMET01260 | |
| 0.062 | 0.134 | 0.14 | Transcription factor NF kappa B stimulant | 0.088 0.053 DBMET00160 0.136 0.019 DBMET01260 0.14 0.018 DBMET01261 | DBMET01261 | |
| 0.035 | 0.106 | 0.193 | Carbonic anhydrase V inhibitor | 0.193 0.008 DBMET01259 | DBMET01259 | |
| 0.007 | 0.08 | 0.802 | Cholecystokinin A agonist | 0.802 0.001 DBMET01259 | DBMET01259 | |
| 0.019 | 0.093 | 0.045 | Oxytocin agonist | 0.045 0.027 DBMET00159 | DBMET00159 | |
| 0.012 | 0.087 | 0.039 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.039 0.022 DBMET00159 | DBMET00159 | |
| 0.015 | 0.089 | 0.029 | Glutamate (mGluR1) agonist | 0.029 0.01 DBMET01259 | DBMET01259 | |
| 0.07 | 0.146 | 0.15 | Nav1.4 sodium channel blocker | 0.11 0.063 DBMET00159 0.15 0.034 DBMET01259 | DBMET01259 | |
| 0.011 | 0.087 | 0.502 | Cholecystokinin antagonist | 0.502 0.003 DBMET01259 | DBMET01259 | |
| 0.05 | 0.127 | 0.122 | NMDA receptor antagonist | 0.122 0.034 DBMET00159 0.11 0.041 DBMET01259 | DBMET00159 | |
| 0.169 | 0.247 | 0.222 | 15-Lipoxygenase inhibitor | 0.222 0.19 DBMET00159 | DBMET00159 | |
| 0.098 | 0.177 | 0.399 | Hemostatic | 0.391 0.008 DBMET01259 0.313 0.014 DBMET01260 0.399 0.008 DBMET01261 | DBMET01261 | |
| 0.149 | 0.231 | 0.185 | Neuropeptide Y2 antagonist | 0.185 0.148 DBMET00159 | DBMET00159 | |
| 0.064 | 0.147 | 0.125 | M18 aspartyl aminopeptidase inhibitor | 0.125 0.067 DBMET00159 | DBMET00159 | |
| 0.006 | 0.092 | 0.803 | Cholecystokinin agonist | 0.803 0.001 DBMET01259 | DBMET01259 | |
| 0.019 | 0.107 | 0.095 | Carbonic anhydrase VB inhibitor | 0.095 0.017 DBMET01259 | DBMET01259 | |
| 0.018 | 0.109 | 0.086 | Phosphorylase inhibitor | 0.053 0.029 DBMET01260 0.086 0.015 DBMET01261 | DBMET01261 | |
| 0.005 | 0.1 | 0.151 | Estrone sulfatase inhibitor | 0.151 0.003 DBMET01259 | DBMET01259 | |
| 0.083 | 0.181 | 0.125 | Mcl-1 antagonist | 0.125 0.118 DBMET00159 | DBMET00159 | |
| 0.049 | 0.155 | 0.086 | Chymotrypsin inhibitor | 0.086 0.048 DBMET01259 | DBMET01259 | |
| 0.08 | 0.189 | 0.112 | Transcription factor STAT6 inhibitor | 0.112 0.076 DBMET00159 | DBMET00159 | |
| 0.025 | 0.134 | 0.365 | Selectin antagonist | 0.104 0.026 DBMET00160 0.213 0.01 DBMET01259 0.351 0.004 DBMET01260 0.365 0.004 DBMET01261 | DBMET01261 | |
| 0.012 | 0.132 | 0.097 | Factor Xa inhibitor | 0.097 0.014 DBMET01259 | DBMET01259 | |
| 0.032 | 0.151 | 0.067 | Sphingosine kinase inhibitor | 0.067 0.029 DBMET01259 | DBMET01259 | |
| 0.006 | 0.126 | 0.525 | Cholecystokinin A antagonist | 0.525 0.003 DBMET01259 | DBMET01259 | |
| 0.011 | 0.133 | 0.039 | 1,3-Beta-glucan synthase inhibitor | 0.039 0.004 DBMET01259 0.03 0.016 DBMET01260 0.03 0.016 DBMET01261 | DBMET01259 | |
| 0.017 | 0.142 | 0.123 | Carbonic anhydrase inhibitor | 0.123 0.021 DBMET01259 | DBMET01259 | |
| 0.005 | 0.131 | 0.456 | Cholecystokinin B antagonist | 0.456 0.003 DBMET01259 | DBMET01259 | |
| 0.077 | 0.207 | 0.443 | Diuretic | 0.443 0.01 DBMET01259 0.119 0.106 DBMET01260 0.205 0.042 DBMET01261 | DBMET01259 | |
| 0.022 | 0.153 | 0.05 | Microtubule stabilization | 0.05 0.029 DBMET01260 0.045 0.035 DBMET01261 | DBMET01260 | |
| 0.017 | 0.153 | 0.795 | Cholecystokinin B agonist | 0.795 0.001 DBMET01259 | DBMET01259 | |
| 0.008 | 0.148 | 0.025 | Dopamine D1 agonist | 0.022 0.017 DBMET01259 0.025 0.013 DBMET01261 | DBMET01261 | |
| 0.061 | 0.202 | 0.107 | Interleukin 12 antagonist | 0.107 0.043 DBMET01261 | DBMET01261 | |
| 0.008 | 0.15 | 0.055 | Carbonic anhydrase XII inhibitor | 0.055 0.035 DBMET01260 | DBMET01260 | |
| 0.018 | 0.165 | 0.103 | NMDA 2 receptor antagonist | 0.072 0.049 DBMET00159 0.103 0.03 DBMET01259 | DBMET01259 | |
| 0.099 | 0.249 | 0.321 | Vasodilator | 0.321 0.041 DBMET01260 0.282 0.055 DBMET01261 | DBMET01260 | |
| 0.024 | 0.174 | 0.046 | Cytokine production stimulant | 0.046 0.042 DBMET01260 | DBMET01260 | |
| 0.018 | 0.171 | 0.051 | Neuraminidase (Influenza A) inhibitor | 0.051 0.023 DBMET01260 0.049 0.025 DBMET01261 | DBMET01260 | |
| 0.126 | 0.279 | 0.382 | Peptidyltransferase inhibitor | 0.18 0.129 DBMET00159 0.276 0.035 DBMET00160 0.359 0.011 DBMET01260 0.382 0.008 DBMET01261 | DBMET01261 | |
| 0.043 | 0.205 | 0.123 | DNA intercalator | 0.105 0.069 DBMET01260 0.123 0.056 DBMET01261 | DBMET01261 | |
| 0.064 | 0.249 | 0.338 | Dual specificity phosphatase 3 inhibitor | 0.338 0.022 DBMET01259 | DBMET01259 | |
| 0.048 | 0.237 | 0.222 | Multidrug resistance-associated protein 1 inhibitor | 0.222 0.007 DBMET01259 0.133 0.036 DBMET01260 | DBMET01259 | |
| 0.066 | 0.27 | 0.335 | Dual specificity phosphatase inhibitor | 0.335 0.023 DBMET01259 | DBMET01259 | |
| 0.09 | 0.3 | 0.129 | MAP kinase kinase 4 inhibitor | 0.129 0.118 DBMET00159 | DBMET00159 | |
| 0.103 | 0.323 | 0.406 | Alpha-glucosidase inhibitor | 0.406 0.112 DBMET01260 0.345 0.138 DBMET01261 | DBMET01260 | |
| 0.013 | 0.233 | 0.071 | Neuraminidase inhibitor | 0.071 0.033 DBMET01260 0.067 0.036 DBMET01261 | DBMET01260 | |
| 0.019 | 0.249 | 0.08 | Neuraminidase (influenza) inhibitor | 0.072 0.032 DBMET01259 0.08 0.026 DBMET01260 0.074 0.031 DBMET01261 | DBMET01260 | |
| 0.107 | 0.351 | 0.346 | Antiobesity | 0.346 0.089 DBMET01259 0.262 0.145 DBMET01261 | DBMET01259 | |
| 0.016 | 0.279 | 0.072 | Antibiotic Aminoglycoside-like | 0.037 0.024 DBMET00160 0.065 0.007 DBMET01260 0.072 0.005 DBMET01261 | DBMET01261 | |
| 0.09 | 0.357 | 0.291 | Angiogenesis inhibitor | 0.291 0.098 DBMET01259 0.226 0.142 DBMET01260 0.211 0.157 DBMET01261 | DBMET01259 | |
| 0.091 | 0.385 | 0.142 | CC chemokine 6 receptor antagonist | 0.142 0.036 DBMET01260 0.141 0.038 DBMET01261 | DBMET01260 | |
| 0.023 | 0.332 | 0.074 | Histone deacetylase SIRT1 stimulant | 0.065 0.061 DBMET01260 0.074 0.05 DBMET01261 | DBMET01261 | |
| 0.023 | 0.332 | 0.074 | Histone deacetylase stimulant | 0.065 0.061 DBMET01260 0.074 0.05 DBMET01261 | DBMET01261 | |
| 0.006 | 0.366 | 0.048 | Protein 30S ribosomal subunit inhibitor | 0.039 0.01 DBMET01260 0.048 0.008 DBMET01261 | DBMET01261 | |
| 0.015 | 0.415 | 0.096 | Thrombin inhibitor | 0.096 0.028 DBMET01259 | DBMET01259 | |
| 0.004 | 0.429 | 0.033 | Factor XI inhibitor | 0.033 0.025 DBMET01259 | DBMET01259 | |
| 0.005 | 0.626 | 0.201 | NMDA 2B receptor antagonist | 0.201 0.005 DBMET01259 | DBMET01259 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |